Together with Novo Nordisk Singapore and HMI Medical, Singlife has launched Singapore’s first insurer-led chronic care programme for weight management. 

Financial services company Singlife has launched the Singlife Chronic Care Programme in partnership with Novo Nordisk Singapore and HMI Medical to support weight management. It is the first insurer-led initiative in Singapore designed to help customers manage obesity, improve health outcomes and address the risk of related chronic diseases. 

“We are helping customers take proactive steps to manage their health before more serious conditions develop. By improving access to obesity treatment, we are providing a better way to support customers on their journey to better health and make preventive care more accessible,” said Akhil Doegar, group head of distribution at Singlife.

The programme provides access to medically guided weight management, including a medical consultation and, where appropriate following assessment, prescription treatment. Available to all Singlife customers, the programme fee is S$289 per month for customers assessed as suitable for the treatment and dosage covered by this rate. Treatment may include a prescription medicine registered with Singapore’s Health Sciences Authority, with the attending doctor determining the appropriate treatment and dosage based on the individual’s health needs and clinical suitability.

“Addressing obesity requires sustained, doctor-led care, but many people still face practical barriers such as cost, convenience or simply knowing where to start,” said Walter Lim, chief executive officer of HMI Singapore. “This partnership helps address those barriers by making structured, evidence-based care easier to access through more than 25 clinics islandwide and telemedicine, while supporting patients with appropriate treatment over time and helping them better manage related metabolic risks such as diabetes, hypertension and high cholesterol.”